✦ LIBER ✦

Up-regulation of MHC class I and class II in the skeletal muscles of myasthenia gravis

✍ Scribed by Kazuo Iwasa; Yuko Kato-Motozaki; Yutaka Furukawa; Takahiro Maruta; Chiho Ishida; Hiroaki Yoshikawa; Masahito Yamada

Book ID: 113730659
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 652 KB
Volume: 225
Category: Article
ISSN: 0165-5728
DOI: 10.1016/j.jneuroim.2010.04.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nerve regulation of class I and Class II

Nerve regulation of class I and Class II-asymmetric forms of acetylcholinesterase in rat skeletal muscles

✍ R. Fadić; Proff. N. C. Inestrosa 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 690 KB

Molecular Immunopathogenesis of Myasthen

Molecular Immunopathogenesis of Myasthenia Gravis Using MHC Class II Mutant and Transgenic Mice

✍ MOHAN SHENOY; CHELLA DAVID; MINAKO OSHIMA; M. ZOUHAIR ATASSI; PREMKUMAR CHRISTAD 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

How Subtle Differences in MHC Class II A

How Subtle Differences in MHC Class II Affect the Severity of Experimental Myasthenia Gravis

✍ Bingzhi Yang; Kevin R. McIntosh; Daniel B. Drachman 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Vacuolar myositis with expression of bot

Vacuolar myositis with expression of both MHC class I and class II antigens on skeletal muscle fibers

✍ Itsuro Higuchi; Michael Nerenberg; Toshiharu Ijichi; Hidetoshi Fukunaga; Kimiyos 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 770 KB

Regulation of class I MHC expression in

Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis

✍ Grace K. Pavlath 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 544 KB

Regulation of the expression of MHC clas

Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells

✍ Aichun Liu; Masuhiro Takahashi; Ken Toba; Zhiyin Zheng; Shigeo Hashimoto; Kohji 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

In order to develop an effective immunotherapy for hematological malignancies, we investigated the applicability of class II transactivator (CIITA), which had been demonstrated to regulate the expression of MHC class II (MHC-II) by assembling the transcription factors of MHC-II molecules, for immuno